Literature DB >> 33961202

Pulmonary hypertension and cardiovascular mortality in end-stage kidney disease: still some way to go before conclusive evidence.

Marieta P Theodorakopoulou1, Georgia Pitsiou2, Afroditi K Boutou3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33961202     DOI： 10.1007/s11255-021-02883-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  2 in total

1.  Erratum.

Authors:  Pantelis A Sarafidis; Charalampos Loutradis; Antonios Karpetas; Georgios Tzanis; Athanasios Bikos; Vassilios Raptis; Christos Syrgkanis; Vassilios Liakopoulos; Aikaterini Papagianni; George Bakris; Gianfranco Parati
Journal:  Nephrol Dial Transplant       Date:  2018-09-19       Impact factor: 5.992

2.  The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients.

Authors:  Merita Rroji; Majlinda Cafka; Saimir Seferi; Joana Seiti; Myftar Barbullushi; Artan Goda
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.